No Data
No Data
The next generation iPhone has a shipping target of over 90 million units within this year.
Apple aims to ship at least 90 million units of its next-generation smart phone, the iPhone 16, in the later half of this year, according to sources. The company reportedly informed its suppliers and partner companies that it aims for a 10% increase in shipment volume compared to the previous model. <4005> Sumitomo Chemical <5201> AGC <5802> Sumitomo Electric Industries
Cocopelli and other stocks with attractive potential based on volume changes.
Brand Closing Price Previous Day's Change Volume<*4167> Cocopeli 471 43 3392200<*3895> Havix 481 29 99200<*9214> Recovery 1493 78 49900<*4222> Kodama Chemical 326 32 210900<*3236> Propast 211 21 807800<*6627> Terapro 4820 440 245600<*776>
Part 2 of the stocks that moved the day before yesterday include Zain, Teraprope, Ise Chemical, etc.
Stock name <Code> 18th closing price ⇒ Compared to the previous day, Enya Fi HD < 2767 > 1648 -72. There is a sense of pause even in the rebound from last weekend. Appier Group < 4180 > 1224 -44. On the 17th, Tōkai Tokyo Securities lowered the target stock price. TOWA < 6315 > 10880 -340. Although the SOX index in the US has risen, the semiconductor sector is heavy. Raccoon HD < 3031 > 546 -14. There is a sense of exhaustion after the earnings report. H.I.S. <960>
Fujita Kan, landlord, Terapro, etc.
<4502> Takeda Pharmaceutical fell sharply by 123 to 4044. It was due to the selling material of the clinical phase 3 trial results of "Soticlestat", a drug being developed for refractory pediatric epilepsy, which were announced the day before. The drug was developed for "Dravet syndrome", which causes repeated seizures, and "Lennox-Gastaut syndrome", which causes weak spells, but it seems that both failed to achieve the main evaluation criteria. The performance impact associated with the current trial results, including impairment losses of intangible assets, will continue to be carefully evaluated.
Terapro - significant rebound, May revenue has achieved double-digit growth for two consecutive months.
Terapro <6627> has rebounded significantly. They announced the monthly trend for May the previous day, which seems to have led to a reassessment. Monthly sales in May increased by 16.3% compared to the same month last year, and has reached double-digit growth for two consecutive months. Since disclosing monthly sales trends in 2022, the company has continued to post positive growth, but in April 2024, it recorded double-digit growth for the first time in 14 months. May appears to be a more significant increase in revenue, and is considered a return to a significant expansion stage.
Active and newly listed stocks during the morning session.
*Fujita Kanko<9722>, up 1000 points, due to restructuring concerns and upward revisions in Four Seasons' performance. *Akebono Brake Industry<7238>, up 20 points, expected to continue buying due to refinancing loan agreement. *Chijyu<3252>, up 257 points, newly rated as "1" by Daiwa Securities. *Nihon Denpa Kogyo<6779>, up 90 points, likely to benefit from the rise of electronic component stocks. *DOWA<5714>, up 416 points, towards group restructuring.
No Data